Cytoreductive Partial Nephrectomy Does Not Undermine Cancer Control in Metastatic Renal Cell Carcinoma: A Population-Based Study (Q59649622)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18799207%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

title

Cytoreductive partial nephrectomy does not undermine cancer control in metastatic renal cell carcinoma: a population-based study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18799207%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

1 reference

metastatic renal cell carcinoma

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18799207%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Claudio Jeldres

series ordinal

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18799207%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

12

Pierre I Karakiewicz

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18799207%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

3

Paul Perrotte

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18799207%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

10

Francesco Montorsi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18799207%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

4

Shahrokh F Shariat

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18799207%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

8

Hugues Widmer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18799207%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

7

Daniel Pharand

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18799207%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

6

Philippe Arjane

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18799207%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

2

Laurent Zini

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18799207%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

author name string

François Péloquin

series ordinal

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18799207%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Jean-Jacques Patard

series ordinal

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18799207%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

language of work or name

English

0 references

publication date

16 September 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18799207%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18799207%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

volume

72

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18799207%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

page(s)

1090-1095

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18799207%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18799207%20AND%20SRC:MED&resulttype=core&format=json

Renal cell carcinoma guideline

14 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.06.059

Cytoreductive nephrectomy for T4NxM1 renal cell carcinoma: the M.D. Anderson Cancer Center experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.06.059

Neoadjuvant sutent induction therapy may effectively down-stage renal cell carcinoma atrial thrombi

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.06.059

Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.06.059

Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.06.059

Cytoreductive nephrectomy in the elderly patient: the M. D. Anderson Cancer Center experience.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.06.059

Cytoreductive nephrectomy in patients with metastatic renal cancer: a combined analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.06.059

The role of nephron sparing surgery for metastatic (pM1) renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.06.059

Cytoreductive nephron-sparing surgery does not appear to undermine disease-specific survival in patients with metastatic renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.06.059

Permanent prostate brachytherapy: a century of technical evolution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.06.059

Differences in the rate of lymph node invasion in men with clinically localized prostate cancer might be related to the continent of origin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.06.059

Tumor size improves the accuracy of TNM predictions in patients with renal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.06.059

Comparison between open partial and radical nephrectomy for renal tumours: perioperative outcome and health-related quality of life

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.06.059

Open radical nephrectomy versus open partial nephrectomy: is it still an issue?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.06.059

Tumor location does not affect long-term renal function after partial nephrectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.06.059

Ability of clinical grade to predict final pathologic stage in upper urinary tract transitional cell carcinoma: implications for therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.06.059

Multi-institutional validation of a new renal cancer-specific survival nomogram

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.06.059

Disparities in treatment and outcome for renal cell cancer among older black and white patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.06.059

Racial disparity in outcomes of a clinical trial population with metastatic renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.06.059

Effects of pathologic stage on the learning curve for radical prostatectomy: evidence that recurrence in organ-confined cancer is largely related to inadequate surgical technique

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.06.059

Variations in morbidity after radical prostatectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.06.059

The rate of lymph node invasion (LNI) in men with PSA values less than 10 ng/ml

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.06.059

Interferon-alfa as a comparative treatment for clinical trials of new therapies against advanced renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.06.059

Multi-institutional validation of a symptom based classification for renal cell carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.06.059

10.1016/J.UROLOGY.2008.06.059

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18799207%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

1 reference